Lv3
302 积分 2024-09-13 加入
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
1天前
已完结
Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction
1天前
求助中
Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats
17天前
已完结
LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation
17天前
已完结
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway
17天前
已完结
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis
22天前
已关闭
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
1个月前
已完结
Epigenetics-targeted drugs: current paradigms and future challenges
1个月前
已完结
Hey2 enhancer activity defines unipotent progenitors for left ventricular cardiomyocytes in juxta-cardiac field of early mouse embryo
1个月前
已完结
Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression
1个月前
已完结
皖公网安备34019202002308
